Search

Displaying results 7091 - 7100 of 8468 in total
  1. Drug

    AM103

    go.drugbank.com/drugs/DB05225
    Experimental

    AM103 is a novel inhibitor of 5-lipoxygenase-activiting protein (FLAP) that has demonstrated potential to treat asthma and cardiovascular disease by preventing the synthesis of LT, which triggers inflammation

  2. Drug

    Emricasan

    go.drugbank.com/drugs/DB05408
    Investigational

    Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA.

  3. Drug

    Ala-geninthiocin

    go.drugbank.com/drugs/DB15657
    Experimental

    [A192840] It has exhibited potent _in vitro_ activity against gram-positive bacteria including _Staphylococcus aureus_, _Bacillus subtilis_, _Mycobacterium smegmatis_, and _Micrococcus luteus_.

  4. Drug

    Omberacetam

    go.drugbank.com/drugs/DB19956
    Experimental

    Omberacetam has a monoisotopic molecular weight of 318.16 Da.

  5. Drug

    Vibozilimod

    go.drugbank.com/drugs/DB21505
    Experimental

    Vibozilimod has a monoisotopic molecular weight of 541.23 Da.

  6. Drug

    Zectivimod

    go.drugbank.com/drugs/DB21525
    Experimental

    Zectivimod has a monoisotopic molecular weight of 527.17 Da.

  7. Drug

    Vormatrigine

    go.drugbank.com/drugs/DB21731
    Investigational

    Vormatrigine has a monoisotopic molecular weight of 406.09 Da.

  8. Drug

    Fidexaban

    go.drugbank.com/drugs/DB19562
    Experimental

    Fidexaban has a monoisotopic molecular weight of 526.18 Da.

  9. Drug

    Lanepitant

    go.drugbank.com/drugs/DB19599
    Experimental

    Lanepitant has a monoisotopic molecular weight of 559.35 Da.

  10. Drug

    Elziverine

    go.drugbank.com/drugs/DB19624
    Experimental

    Elziverine has a monoisotopic molecular weight of 543.27 Da.